神经病理性疼痛
医学
上瘾
定性研究
医疗保健
梅德林
疼痛管理
不利影响
物理疗法
精神科
麻醉
社会学
法学
经济
内科学
经济增长
社会科学
政治学
作者
Eva Widerström-Noga,Kim D. Anderson,Salomé Perez,Alberto Martinez‐Arizala,Lindsey Calle-Coule,Loriann Fleming
出处
期刊:Pain Medicine
[Oxford University Press]
日期:2020-02-18
卷期号:21 (11): 2913-2924
被引量:18
摘要
Persistent neuropathic pain is a common and often severe consequence of spinal cord injury (SCI). There is a critical need to better understand how to overcome barriers and promote facilitators to optimal pain management. The present study was designed to identify, from the perspectives of persons living with SCI, their significant others, and SCI health care professionals, the barriers and facilitators to optimal pain management for intense neuropathic pain.Qualitative interviews.University laboratory.People with SCI who had experienced intense neuropathic pain for a minimum of a year (N = 15), their significant others (N = 15), and SCI health care providers (N = 15).Qualitative interviews were recorded, transcribed, and analyzed based on grounded theory using ATLAS.ti software.Inadequate access to care, information, or pain management expertise were frequently perceived barriers to optimal pain management across all three groups. Another major barrier was SCI stakeholders' concerns regarding the risks of adverse effects and addiction to pain medication. Facilitators included having a better understanding of pain and available treatment options, effective patient-provider communication, resilience, and access to nonpharmacological treatment options.Managing intense neuropathic pain poses significant challenges after SCI. SCI stakeholders felt that accessible treatment options were limited and primarily focused on pain medications with minimal benefit but with significant risks for addiction and adverse effects. Actionable facilitators to optimal pain management after SCI include education regarding neuropathic pain and treatment options for all stakeholders, better communication regarding neuropathic pain among stakeholders, and improved patient access to nonpharmacological treatment options.
科研通智能强力驱动
Strongly Powered by AbleSci AI